What is the recommended cream for treating eczema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Creams for Eczema Management

For eczema treatment, fragrance-free emollients should be used as the foundation of therapy, with topical corticosteroids added during flares, with potency selected based on severity and location of eczema. 1

First-Line Treatment: Emollients

Emollient Selection and Application

  • Base therapy: Liberal use of fragrance-free emollients is the cornerstone of eczema management
  • Apply emollients 3-8 times daily, especially immediately after bathing while skin is still slightly damp 1
  • Formulation selection:
    • Ointments: Best for very dry skin and winter months
    • Creams: Good balance between moisturization and cosmetic acceptability
    • Lotions: Preferred in hot, humid weather (less moisturizing)
    • Recommended options: 10% urea cream, white soft paraffin, emulsifying ointment 2, 1

Application Amounts (per 2 weeks)

  • Face and neck: 15-30g
  • Both hands: 15-30g
  • Both arms: 30-60g
  • Both legs: 100g
  • Trunk: 100g 2

Topical Corticosteroids for Flares

Potency Selection Based on Severity

  1. Mild eczema: Low-potency corticosteroids

    • Hydrocortisone 0.1-2.5% 1, 3
    • Dioderm (hydrocortisone 0.1%)
  2. Moderate eczema: Medium-potency corticosteroids

    • Eumovate (clobetasone butyrate 0.05%)
    • Betnovate-RD (betamethasone valerate 0.025%) 2, 1
  3. Severe eczema: High-potency corticosteroids (short-term use)

    • Betnovate (betamethasone valerate 0.1%)
    • Elocon (mometasone 0.1%) 2, 1
  4. Very severe/refractory eczema: Very high-potency corticosteroids

    • Dermovate (clobetasol propionate 0.05%)
    • Nerisone Forte (diflucortolone valerate 0.3%) 2, 1

Application Frequency

  • Once daily application of potent topical corticosteroids is as effective as twice daily application 4
  • Use for short periods (2-4 weeks) to avoid side effects 1
  • For prevention of flares, consider weekend/proactive therapy (twice weekly application) which reduces relapse risk from 58% to 25% 4

Special Considerations

Infection Management

  • If signs of infection present, consider:
    • Topical antibiotics in alcohol-free formulations 2
    • Antiseptic washes with aqueous chlorhexidine 0.05% for erosive lesions 1
    • Bleach baths with 0.005% sodium hypochlorite twice weekly to help prevent infections 1

Cautions

  • Monitor for skin thinning, especially with higher-potency corticosteroids 4
  • Fucidin-containing combination creams may lead to antibiotic resistance with prolonged use 5
  • The order of application between emollients and corticosteroids does not significantly affect treatment outcomes - allow 15 minutes between applications 6

When to Refer

  • Diagnostic uncertainty
  • Failure to respond to appropriate topical steroids
  • Need for second-line treatments (systemic therapies) 1

Patient Education Points

  • Demonstrate proper application technique to patients/caregivers
  • Explain that hydrocortisone is a mild steroid (31% of patients incorrectly classify its potency) 7
  • Address "steroid phobia" - 72.5% of patients worry about using topical corticosteroids, affecting compliance 7
  • Emphasize that consistent emollient use, even when skin appears normal, is essential for management 1

Remember that the most effective emollient is one that the patient will actually use consistently, considering their preferences and climate conditions.

References

Guideline

Eczema Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Strategies for using topical corticosteroids in children and adults with eczema.

The Cochrane database of systematic reviews, 2022

Research

Topical corticosteroid phobia in patients with atopic eczema.

The British journal of dermatology, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.